By Iain Gilbert
Date: Tuesday 26 Aug 2025
(Sharecast News) - Diagnostics business EKF Diagnostics said on Tuesday that it has signed three new contracts in its key organic growth area of Hematology point-of-care testing, worth approximately €4.65m.
Long Term Incentive Plan | 16-Sep-2025 | 07:15 | RNS |
Half-year Report | 16-Sep-2025 | 07:00 | RNS |
Notice of interim results | 10-Sep-2025 | 07:00 | RNS |
Hematology contracts signed worth EUR 4.65m | 26-Aug-2025 | 07:00 | RNS |
H1 2025 Trading Update | 28-Jul-2025 | 07:00 | RNS |
Database | 28-Oct-2006 | Telegraph |
Pollster gets the vote | 22-Jan-2006 | Scotland on Sunday |
No recent information was found.
No recent information was found.
Currency | UK Pounds |
Share Price | 29.90p |
Change Today | 0.90p |
% Change | 3.10 % |
52 Week High | 31.90 |
52 Week Low | 18.75 |
Volume | 1,171,014 |
Shares Issued | 449.09m |
Market Cap | £134.28m |
Beta | 0.01 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 3 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 4 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 02-Nov-23 | 03-Nov-22 |
Paid | 01-Dec-23 | 01-Dec-22 |
Amount | 1.20p | 1.20p |
Time | Volume / Share Price |
12:19 | 282,580 @ 30.00p |
12:11 | 350,000 @ 30.00p |
12:11 | 246,545 @ 30.00p |
16:35 | 31 @ 29.90p |
16:35 | 28 @ 29.90p |
CFO | Stephen (Steve) Young |
CEO | Gavin T Jones |
You are here: research